Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neurofibromatosis 1 3Warts 1Recurrence 1Port-Wine Stain 1Periodontitis 1Neurofibromatoses 1Lymphoma, Follicular 1Leukoplakia 1Laryngeal Neoplasms 1Hemangioma, Capillary 1Chronic Periodontitis 1Carcinoma 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Lasers, Solid-State × Clear all
NCT03233165 2017-07-28

Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral Leukoplakia

University of Zagreb

Phase NA Completed
54 enrolled
Head & Neck

Leukoplakia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡